SOD1 and ischemia: Furthermore, this treatment increased the SOD (Fig. 4B) and GSH (Fig. 4C) activities by approximately 55.00% and 131.08%, respectively, compared with the ischaemia group, and by about 43.00% and 149.00%, respectively, compared with the control group.